About
After more than 30 years of scientific research de Faire Medical AB was founded in 2021with a clear Vision uncovering the full potential of applying microbial solutions to a specific organic substrate, and a unique technology of targeting bacterial strains into functional dietary supplements
Our History
1970 – 1980
Early observations that farmed animals suffering from intestinal inflammations recovered from eating fermented rice bran.
In late 1990s, a pro-/prebiotic dietary supplement for human uses was developed and safety studies designed as open case studies were initiated. No side effects or adverse reactions were detected as a single treatment or concomitantly with other commonly used drugs, i.e. anti-inflammatory, heart medicines, antibiotics and more
In the early 2000 catalytic targeting of consortium for preferential metabolic actions was developed
2010-2020
First study on alcohol digestion was conducted
In 2020 an additional study on alcohol digestion and a study on Type 2 diabetes were conducted with most positive outcomes.
In February 2021 de Faire Medical AB was incorporated
July 2022
Launch of Myrkl in the UK & Ireland